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Cardiovascular risk in an adult CF population: a 10 year retrospective analysis 
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Objectives: 1) To characterise changes in cardiovascular risk factors in an adult population over a 10 year period. 2) 
To determine whether any difference exists between pancreatic sufficient versus insufficient subjects  
Methods: Data was extracted retrospectively from an electronic clinical record (ECR) for all patients registered in 
2017 who had attended the adult CF regional centre for 10 years. Weight, height, BMI, cholesterol, cholesterol:HDL 
ratio, triglyceride, systolic blood pressure , diastolic blood pressure, pancreatic sufficiency were recorded at 3 tim e 
points [2008,2013,2017] for each subject.  Cardiovascular risk was assessed for a) the entire population and b) 
pancreatic sufficient versus insufficient subjects. Paired and unpaired tests were used to assess differences at time 
points 
Results: Of the 424 patients registered within this time period, 214(126 male) had values recorded for 2008, 2013 
and 2017. Of this sample (n=214), mean age was 37.6 (±8.48) years and 24/212 (11.3%) were pancreatic sufficient. 
(Table 1) 
Year 
 
Weight 
(kg) 
 
Height 
(m) 
 
BMI 
(Kg/m2) 
 
Cholesterol 
(mmol/l) 
 
Cholesterol:HDL 
ratio 
 
Triglyceride 
(mmol/l) 
 
Systol ic 
BP 
(mmHg) 
 
Diastolic 
BP 
(mmHg) 
 
2008 65.3 1.68 22.8 3.84 2.81 1.22 121.4 73.5 
 
2013 66.8 1.68 23.2 3.98 2.81 1.42 127.4 77.6 
 
2017  67.5 1.68 23.6 4.19 2.96 1.41 126.3 77.9 
 
Sig. p<0.001 p=0.5 p<0.001 p=0.002 p=0.11 p=0.008 p<0.001 p<0.001 
 
 [Table 1: CVD risk factors 2008-2017] 
Pancreatic insufficient (PI) and sufficient (PS) patients, BMI (kg/m2) and cholesterol (mmol/l) were significantly 
different between status across each year (Table 2). 
 
Year  
 
BMI (Kg/m2) Cholesterol 
(mmol/l) 
 
Cholesterol:HDL 
ratio 
 
Triglyceride 
(mmol/l) 
 
Systol ic BP 
(mmHg) 
 
Diastolic BP 
(mmHg) 
 
 PI v PS PI v PS PI v PS PI v PS PI v PS PI v PS 
 
2008 22.4 v 25.8** 3.77 v 4.48* 2.81 v 3.21 1.23 v 1.04 121.0 v 124 73.2 v 76.1 
 
2013 23.0 v 25.7** 3.89 v 4.74** 2.81 v 3.50* 1.45 v 1.18 126.7 v 132.9 77.8 v 76.0 
 
2017 23.2 v 26.4** 4.08 v 5.07* 2.96 v 3.48 1.41 v 1.37 126.3 v 125.7 78.1 v 76.4 
 
*p<0.01 **p<0.001 
 
     
 [Table 2 Risk factors for CVD (PI v PS)] 
Conclusion: Values for CVD risk factors documented have risen across a 10 year time period. In PS patients mean 
cholesterol values in 2017 (5.05mmol/l) exceed the UK recommendation (5.0mmol/l).  
